X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

十月 10, 2019

New FDA Guidance on “Considerations in Demonstrating Interchangeability with a Reference Product” – How West is Working to Support Biosimilar Companies

The development of new biosimilar products has increased over the past several years. Europe and Asia Pacific have been leading the industry with the greatest number of biosimilars being introduced to the market. Given the demand to reduce medical costs for patients, this trend is expected to increase globally in the coming years.
Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • 以前的博客
    Introducing Integrated Solutions

    五月 02, 2019

    FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

    Amy Kim

    Amy Kim

    Sr. Specialist, Scientific Communications, SA & TS

    SmartDose Injection Platform in Use

    十月 16, 2018

    Medical Device User Fee Rates

    Ana Ladino

    Ana Ladino

    Director, Regulatory Affairs

    四月 16, 2014

    New FDA Guidance Issued for Annual Reportable Changes

    Steve LoCastro

    Director, Regulatory Affairs

    Load more